Search results
Ionis (IONS), AstraZeneca's Amyloidosis Drug Meets Study Goals
Zacks via Yahoo Finance· 2 years agoIonis (IONS), along with partner AstraZeneca, reports positive data from a phase III study, which is...
Ionis (IONS), along with partner AstraZeneca, reports positive data from a phase III study, which is...